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Letter to the Editor
New guidelines have recently been introduced (ISO 
15197:2013(E)) by the International Organization for 
Standardization to establish acceptable performance for 
blood glucose monitoring systems (BGMS).1 In this study 
the accuracy of the blood glucose readings provided by the 
AgaMatrix WaveSense JAZZ BGMS, which is a handheld 
BGMS that requires 0.5µl capillary whole blood, was stud-
ied when compared to a laboratory reference method. The 
BGMS test strip contains glucose oxidase with a redox 
chemical mediator that produces an electrochemical signal 
in proportion to the concentration of glucose in the blood. 
The meter measures the signal using multiple measurements 
and reanalyzing the input stimulation signal in response to 
how the chemistry is progressing to correct for common 
interferents.
The study was performed within the Diabetes Research 
Network Wales, Swansea University in compliance with 
good clinical practice (GCP) guidelines and approved by the 
relevant ethics committee.
System accuracy was evaluated for 100 subjects spanning 
a wide concentration range (1.50-24.75 mmol/L). Fresh cap-
illary blood samples were collected from the fingertip of the 
subject’s hand. A predetermined number of samples were 
assigned to each of 7 concentration subgroups to ensure even 
distribution across the range. In accordance with the ISO 
15197 guidelines an agreed number of samples were modi-
fied to meet the extreme glucose concentrations and adjusted 
to have pO
2
 concentrations equivalent to capillary blood 
prior to assay.
Plasma glucose was analyzed using a YSI 2300 Stat Plus 
(Yellow Springs Instruments, Fleet, UK) as the reference 
method and blood glucose was determined on 6 different 
BGMS meters with 3 lots of test strips, which were all pro-
vided by the manufacturer. For YSI measurement, blood 
samples were collected into capillary collection tubes 
(Lithium Heparin Microvette, Sarstedt, Leicester, UK) and 
centrifuged prior to plasma glucose measurement. In 
addition, hematocrit was measured using a Hemo Control 
analyzer (EKF, Cardiff, UK). Daily control measures were 
carried out on all meters and instruments. Other than in the 
modified samples, all blood sampling and analysis were per-
formed within a 5-minute time frame.
The blood glucose results from 3 different lots of test 
strips (200 samples/lot) showed excellent agreement and lin-
earity with results from the YSI (R2 = .9894-.9924). No dif-
ference between lots could be observed (P = .974). Overall 
99% of the readings from the 6 BGMS meters met each of 
the individual criteria. At glucose concentrations 
<5.5mmol/L, 208/210 (97% [lot 1] and 100% [lots 2 and 3]) 
results fell within ±0.83 mmol/L of the YSI values. At glu-
cose concentrations ≥5.5 mmol/L, 385/390 (99% [lot 1] and 
98% [lots 2 and 3]) results fell within ±15% as specified by 
ISO 15197:2013. The overall combined results, also speci-
fied, demonstrated conformance (593/600 [99%] within 
±0.83 mmol/L and within ±15%). Of values, 100% fell 
within zone A of the consensus error grid, defined as “clini-
cally accurate measurements” as shown in Figure 1B.2
This study demonstrates that the system has excellent 
agreement with a reference laboratory method and exceeds 
the minimum acceptable system accuracy criteria specified 
by ISO 15197:2013.
Abbreviations
BGMS, blood glucose monitoring system; GCP, good clinical prac-
tice; ISO, International Organization for Standardization; YSI, 
Yellow Springs Instruments.
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Figure 1. (A) System accuracy plot for BGMS glucose vs YSI 2300 plasma glucose concentration. Data shown are from all 3 test strip 
lots. Area inside the solid lines represents minimum acceptable accuracy from ISO 15197:2013. (B) Consensus error grid plot of BGMS 
glucose concentrations vs YSI 2300 plasma glucose. In all, 600 data points shown (100 samples measured in duplicate on each meter).
